Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-10-02
|
ST-400 |
transfusion-dependent beta-thalassemia |
1-2 |
Bioverativ (USA - MA) Sangamo Biosciences (USA - MA) |
Rare diseases - Genetic diseases - Hematological diseases |
2017-10-02
|
VB-111 (ofranergene obadenovec) |
glioblastoma |
3 |
VBL Therapeutics (Israel) |
Cancer - Oncology |
2017-10-02
|
PRS-343 |
HER2-positive solid tumors |
1 |
Pieris (Germany) |
Cancer - Oncology |
2017-09-30
|
bb2121, anti-BCMA CAR T cells |
relapsed/refractory multiple myeloma |
1 - OLE |
Bluebird bio (USA - MA) |
Cancer - Oncology |
2017-09-30
|
epacadostat and Keytruda® (pembrolizumab) |
advanced tumors |
1-2 |
Incyte (USA - DE) Merck&Co (USA - NJ) |
Cancer - Oncology |
2017-09-29
|
FYB201 (biosimilar ranibizumab ) biosimilar version of Lucentis® |
wet age-related macular degeneration (wet AMD) |
3 |
Formycon (Germany) bioeq GmbH (Germany) |
Ophtalmological diseases |
2017-09-29
|
ZX008 (fenfluramine hydrochloride) |
Dravet syndrome |
3 |
Zogenix (USA - NY) |
Rare diseases - Neurological diseases |
2017-09-28
|
NeuVax™ (nelipepimut-S) |
node-positive breast cancer |
3 |
Galena Biopharma (USA - OR) |
Cancer - Oncology |
2017-09-28
|
ABX464 |
HIV infection |
1-2 |
Abivax (France) |
Infectious diseases |
2017-09-28
|
bb21217 |
relapsed/refractory multiple myeloma |
1 |
Bluebird bio (USA - MA) |
Cancer - Oncology |
2017-09-28
|
Ery-asp®/Graspa® (eryaspase - L-asparaginase loaded erythrocytes) |
acute lymphoblastic leukemia (ALL) |
1 |
Erytech Pharma (France) |
Cancer - Oncology |
2017-09-28
|
AsiDNA™ and belinostat |
|
preclinical |
Onxeo (France) |
Cancer - Oncology |
2017-09-28
|
pembrolizumab and olaptesed pegol (NOX-A12) |
metastatic colorectal cancer, metastatic pancreatic cancer |
1-2 |
Noxxon Pharma (Germany) Merck&Co (USA - NJ) |
Cancer - Oncology |
2017-09-27
|
THR-687 |
|
preclinical |
Thrombogenics (Belgium) |
|
2017-09-27
|
Remygen® (gamma-Aminobutyric acid) |
|
|
Diamyd Medical (Sweden) |
|
2017-09-27
|
RAD140 |
hormone receptor positive breast cancer |
1 |
Radius Health (USA - MA) |
Cancer - Oncology |
2017-09-25
|
SYL136001v10 |
neovascular diseases of the retina including age related macular degeneration (AMD) |
preclinical |
Sylentis (Spain) |
Ophtalmological diseases |
2017-09-25
|
ARB-1467 |
hepatitis B |
2 |
Arbutus Biopharma (Canada) |
Infectious diseases |
2017-09-25
|
QR-010 |
cystic fibrosis |
1b |
ProQR Therapeutics (The Netherlands) |
Rare diseases - Genetic diseases - Lung diseases |
2017-09-22
|
Keyzilen™ (AM-101) |
acute peripheral tinnitus |
3 |
Auris Medical (Switzerland) |
Otorhinolaryngology |